Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence
about
Solution structure of a retro-inverso peptide analogue mimicking the foot-and-mouth disease virus major antigenic site. Structural basis for its antigenic cross-reactivity with the parent peptideA Brief Review on Diagnosis of Foot-and-Mouth Disease of Livestock: Conventional to Molecular ToolsThe impact of new technologies on vaccine development.Mimotopes: realization of an unlikely concept.In-vitro and in-vivo phenotype of type Asia 1 foot-and-mouth disease viruses utilizing two non-RGD receptor recognition sites.The recognition of proteins and peptides by antibodies.Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine.Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse geneticsPrediction of sequential antigenic regions in proteins.Immunogenicity of two FMDV nonameric peptides encapsulated in liposomes in mice and the protective efficacy in guinea pigsResearch in advance for FMD novel vaccinesHow foot-and-mouth disease virus receptor mediates foot-and-mouth disease virus infection.Identification of H-2d restricted T cell epitope of foot-and-mouth disease virus structural protein VP1Time Clustered Sampling Can Inflate the Inferred Substitution Rate in Foot-And-Mouth Disease Virus Analyses.Foot-and-mouth disease: overview of motives of disease spread and efficacy of available vaccinesEvolution subverting essentiality: dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus.Towards a hepatitis A vaccine. A review.Cross-reactions of immunoglobulin M and G antibodies with enterovirus-specific viral structural proteins.Genome variation in the SAT types of foot-and-mouth disease viruses prevalent in buffalo (Syncerus caffer) in the Kruger National Park and other regions of southern Africa, 1986-93.A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies.Vaccination against foot-and-mouth disease virus: strategies and effectiveness.B epitope multiplicity and B/T epitope orientation influence immunogenicity of foot-and-mouth disease peptide vaccines.Artificially designed recombinant protein composed of multiple epitopes of foot-and-mouth disease virus as a vaccine candidate.Basic concepts and new aspects of vaccine development.Novel transgenic rice-based vaccines.An Australian perspective of foot-and-mouth disease research.Antibody response to bacterial antigens covalently bound to biodegradable polymerized serum albumin beads.Identification of a conserved linear neutralizing epitope recognized by monoclonal antibody 9A9 against serotype A foot-and-mouth disease virus.A recombinant porcine circovirus type 2 expressing the VP1 epitope of the type O foot-and-mouth disease virus is infectious and induce both PCV2 and VP1 epitope antibodies.Single amino acid substitution of VP1 N17D or VP2 H145Y confers acid-resistant phenotype of type Asia1 foot-and-mouth disease virus.New approaches to animal vaccines utilizing genetic engineering.Sindbis virus replicase-based DNA vaccine construct encoding FMDV-specific multivalent epitope gene: studies on its immune responses in guinea pigs.Vaccines for the future--an update.Biotechnological approach to a new foot-and-mouth disease virus vaccine.Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus.The immunological adjuvant and vaccine carrier properties of liposomes.Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle.Dendrimeric peptides can confer protection against foot-and-mouth disease virus in cattle.Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site.Frameshifting in the expression of the Escherichia coli trpR gene.
P2860
Q27766742-E134C61C-D403-4103-B55B-6397AF52454BQ28742691-700CCCD3-F287-49D0-BFA7-F0A42186895DQ30411839-21BDEBB0-ADBE-455D-A0CD-DB1520AC0E3FQ30976506-AF07440D-74CB-4F4E-8DCF-2C6B4516996CQ33944915-36F7A874-9E85-4D01-8FB4-A9DB68B66A78Q33993576-CADFBFCC-05B4-4241-B0A1-CBEB4198D224Q34225659-A5DFE43B-C4DE-47CE-B7DD-A084097931F0Q34271606-6D7EC70D-3B92-402C-ABB2-505E65636C3DQ34377036-C5EAD91F-EC54-4360-A353-A7778F684384Q34850165-3F0718CC-9FB9-43E4-B582-E6B1530EF72BQ35054750-C854D240-7DF4-4462-AC2C-A19A1F9FE465Q35066053-C76228A3-1FB0-4ACA-A39C-5CB5304DF167Q35231344-CF4D3471-F885-4E37-8222-7691B20A59F2Q35859056-CFFAC77F-44FB-47EC-9946-21AA9C0625F7Q35966608-C41F8169-BA3B-452B-A2C0-20F4A7ADCB37Q36240271-FBAF9DBA-C977-4E1F-BDA4-4D68C2450464Q36250007-35255D8F-B3D4-4832-9E09-11880DE937E4Q36250225-BD904BA5-F2E3-4A20-99C6-2B66E6DF49D3Q36503746-E0D6D16D-7522-496F-91B1-0AEC84C5BE05Q36822090-DCCBDD21-6D5C-48BD-AE15-10F8DC828763Q37403499-84A58219-4C7F-42EB-9F53-94749D8A9BB5Q37426707-21FBE468-0D45-471C-AD3E-629B5C4652E3Q37661480-969BA7CF-0CA2-47AD-A50B-8925DD8F4794Q38202927-2DFC9808-5CBA-4F02-B4E7-42003565F55EQ38229883-3BB25C9D-B80A-45BA-B276-EF7BD42D39E3Q38322046-EF39AB5A-8DF2-420D-9008-01248DA64893Q38594804-8538A448-6ABD-4102-8DDC-D7EDF9B8367AQ38841363-02C90226-C1C0-4B2F-BCD5-A8C2AA96D279Q38966668-C8E50087-BF68-42D3-AD7E-B72E864E8536Q39002258-321ECFB0-82A9-4F73-85C3-EF4A661D43DBQ39217754-8CC4D976-4C7D-48A9-92DE-7D5B41F8C079Q39330599-421A83DC-F0AE-4D89-AB80-6DB204FE1C0DQ39596006-8EB0E833-EBE8-4833-B2C3-E207813A9251Q40076493-23329DCA-AE49-4A11-8823-CAEF699C5CA3Q40154156-963A35B0-9256-45D9-B125-733E5A0E9F70Q40499082-7EC149A5-0405-4D7A-8F21-D28D75AABBBFQ41670656-0965CB4D-34AD-4206-A618-272F3CC32099Q41806887-C9FC3D93-644F-4495-B67A-7C394477418AQ42046690-C5584FFB-71FF-4CE2-A46F-76F148A583ACQ42605102-F84495CA-64FB-4864-BF7E-40C165F7D146
P2860
Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence
description
article publié dans la revue scientifique Nature
@fr
scientific article published in Nature
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в Nature в липні 1982
@uk
name
Protection against foot-and-mo ...... the viral nucleotide sequence
@en
Protection against foot-and-mo ...... the viral nucleotide sequence
@nl
type
label
Protection against foot-and-mo ...... the viral nucleotide sequence
@en
Protection against foot-and-mo ...... the viral nucleotide sequence
@nl
prefLabel
Protection against foot-and-mo ...... the viral nucleotide sequence
@en
Protection against foot-and-mo ...... the viral nucleotide sequence
@nl
P2093
P356
P1433
P1476
Protection against foot-and-mo ...... the viral nucleotide sequence
@en
P2093
D J Rowlands
H Alexander
J G Sutcliffe
J L Bittle
R A Houghten
R A Lerner
T M Shinnick
P2888
P356
10.1038/298030A0
P407
P577
1982-07-01T00:00:00Z
P6179
1049090502